» Articles » PMID: 17151361

Mel-18, a Polycomb Group Protein, Regulates Cell Proliferation and Senescence Via Transcriptional Repression of Bmi-1 and C-Myc Oncoproteins

Overview
Journal Mol Biol Cell
Date 2006 Dec 8
PMID 17151361
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Polycomb group (PcG) protein Bmi-1 is an important regulator of cell proliferation. It regulates cellular senescence and proliferation of cells via the transcriptional repression of INK4a/ARF locus and other target genes. Here, we report that Mel-18, a PcG ring finger protein (PCGF) transcriptionally down-regulates Bmi-1. Furthermore, the expression of Bmi-1 and Mel-18 inversely correlates in proliferating and senescent human fibroblasts. Bmi-1 down-regulation by Mel-18 results in accelerated senescence and shortening of the replicative life span in normal human cells. Importantly, using promoter-reporter, chromatin immunoprecipitation, and quantitative real-time primary transcript RT-PCR assays, and an RNA interference approach, we demonstrate that Bmi-1 is a bona fide target of c-Myc oncoprotein. Finally, our data suggest that Mel-18 regulates Bmi-1 expression during senescence via down-regulation of c-Myc. These studies link c-Myc and polycomb function in cell proliferation and senescence.

Citing Articles

Canonical and non-canonical PRC1 differentially contribute to regulation of neural stem cell fate.

Hoffmann J, Schutze T, Kolodziejczyk A, Kuster K, Krankel A, Reinhardt S Life Sci Alliance. 2025; 8(4).

PMID: 39933923 PMC: 11814486. DOI: 10.26508/lsa.202403006.


Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications.

Balamurli G, Liew A, Tee W, Pervaiz S Redox Biol. 2024; 78:103441.

PMID: 39612910 PMC: 11629570. DOI: 10.1016/j.redox.2024.103441.


Acute Lymphoblastic Leukemia in a Pediatric Patient With Turnpenny-Fry Syndrome.

Patricio Rodrigues I, Teixeira B, Capela A, Almeida M, Falcao Reis C Cureus. 2024; 16(1):e53099.

PMID: 38283775 PMC: 10822196. DOI: 10.7759/cureus.53099.


Low gamma-butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach.

Kim K, Moon K, Min K, Jung W, Shin S, Lee S J Pathol Clin Res. 2023; 9(3):236-248.

PMID: 36864013 PMC: 10073934. DOI: 10.1002/cjp2.315.


Bmi-1: A master regulator of head and neck cancer stemness.

Herzog A, Somayaji R, Nor J Front Oral Health. 2023; 4:1080255.

PMID: 36726797 PMC: 9884974. DOI: 10.3389/froh.2023.1080255.


References
1.
Dimri G, Itahana K, Acosta M, Campisi J . Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol. 1999; 20(1):273-85. PMC: 85083. DOI: 10.1128/MCB.20.1.273-285.2000. View

2.
Kleer C, Cao Q, Varambally S, Shen R, Ota I, Tomlins S . EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A. 2003; 100(20):11606-11. PMC: 208805. DOI: 10.1073/pnas.1933744100. View

3.
Pickart C . Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001; 70:503-33. DOI: 10.1146/annurev.biochem.70.1.503. View

4.
Dimri G, Martinez J, Jacobs J, Keblusek P, Itahana K, van Lohuizen M . The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 2002; 62(16):4736-45. View

5.
Varambally S, Dhanasekaran S, Zhou M, Barrette T, Kumar-Sinha C, Sanda M . The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002; 419(6907):624-9. DOI: 10.1038/nature01075. View